Answers are grounded in this paper and cite their sources.
This study provides the first in vivo structural evidence that MyBP-C bridges thick and thin filaments by binding to actin, revealing a physical mechanism that could modulate muscle contraction.
Myosin-binding protein C (MyBP-C) is a thick filament protein playing an essential role in muscle contraction, and MyBP-C mutations cause heart and skeletal muscle disease in millions worldwide. Despite its discovery 40 y ago, the mechanism of MyBP-C function remains unknown. In vitro studies suggest that MyBP-C could regulate contraction in a unique way--by bridging thick and thin filaments--but there has been no evidence for this in vivo. Here we use electron tomography of exceptionally well preserved muscle to demonstrate that MyBP-C does indeed bind to actin in intact muscle. This binding implies a physical mechanism for communicating the relative sliding between thick and thin filaments that does not involve myosin and which could modulate the contractile process.
No takes yet. Share an insight, caveat, or question.
Luther et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: